Cargando…

Current and future applications of the anti-IgE antibody omalizumab

IgE antibodies are a pivotal factor in pathophysiology of allergic diseases, and the possibility of reducing their level by anti-IgE has long been envisioned. Following several attempts, an effective biologic agent was obtained with the recombinant humanized mono-clonal antibody (rhuMAb)-E25, known...

Descripción completa

Detalles Bibliográficos
Autores principales: Incorvaia, Cristoforo, Mauro, Marina, Riario-Sforza, Gian Galeazzo, Frati, Franco, Tarantini, Francesco, Caserini, Maurizio
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2727776/
https://www.ncbi.nlm.nih.gov/pubmed/19707429